A small library of chalcones induce liver cancer cell death through Akt phosphorylation inhibition

Download

10.1038:s41598-020-68775-9.pdf

Date

2020-7-16

Author

Sahin, Irem Durmaz
Christodoulou, Michael S.
Guzelcan, Ece Akhan
Koyas, Altay
Karaca, Cigdem
Passarella, Daniele
Atalay, Rengül

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

249
views

125
downloads

Hepatocellular carcinoma (HCC) ranks as the fifth most common and the second deadliest cancer worldwide. HCC is extremely resistant to the conventional chemotherapeutics. Hence, it is vital to develop new treatment options. Chalcones were previously shown to have anticancer activities in other cancer types. In this study, 11 chalcones along with quercetin, papaverin, catechin, Sorafenib and 5FU were analyzed for their bioactivities on 6 HCC cell lines and on dental pulp stem cells (DPSC) which differentiates into hepatocytes, and is used as a model for untransformed control cells. 3 of the chalcones (1, 9 and 11) were selected for further investigation due to their high cytotoxicity against liver cancer cells and compared to the other clinically established compounds. Chalcones did not show significant bioactivity (IC50>20 mu M) on dental pulp stem cells. Cell cycle analysis revealed that these 3 chalcone-molecules induced SubG1/G1 arrest. Akt protein phosphorylation was inhibited by these molecules in PTEN deficient, drug resistant, mesenchymal like Mahlavu cells leading to the activation of p21 and the inhibition of NF kappa B-p65 transcription factor. Hence the chalcones induced apoptotic cell death pathway through NF kappa B-p65 inhibition. On the other hand, these molecules triggered p21 dependent activation of Rb protein and thereby inhibition of cell cycle and cell growth in liver cancer cells. Involvement of PI3K/Akt pathway hyperactivation was previously described in survival of liver cancer cells as carcinogenic event. Therefore, our results indicated that these chalcones can be considered as candidates for liver cancer therapeutics particularly when PI3K/Akt pathway involved in tumor development.

Subject Keywords

Multidisciplinary, NF-KAPPA-B, PATHWAY, PACLITAXEL, SCAFFOLD, THERAPY, KINASES, GROWTH, PTEN

URI

https://hdl.handle.net/11511/51439

Journal

Scientific Reports

DOI

https://doi.org/10.1038/s41598-020-68775-9

Collections

Graduate School of Informatics, Article

Suggestions

OpenMETU
Core

A new thiadiazine derivative induces oxidative stress dependent JNK pathway activation and cell death in hepatocellular carcinoma Kahraman, Deniz Cansen; TOZKOPARAN KÖPRÜCÜ, BİRSEN; Atalay, Rengül (2019-07-01) Hepatocellular carcinoma (HCC) is the fifth most common and the second lethal cancer worldwide. HCC is resistant to conventional chemotherapy and radiotherapy due to its highly heterogenous structure. Therefore, it is crucial to design and develop novel therapeutic strategies against HCC. Non-steroidal anti-inflammatory drugs (NSAIDs) have long been studied for the treatment of acute and chronic conditions with pain and inflammation. In recent years, evidence from various studies suggested that NSAIDs reduc...
In silico modeling and in vitro validation of undefined off-target of drugs in hepatocellular carcinoma Sinoplu, Esra; Tunçbağ, Nurcan; Kahraman, Deniz C.; Atalay, Rengül (2019-07-01) Hepatocellular carcinoma (HCC) is the 5th most common and 2nd deadliest cancer worldwide. The molecular mechanism in HCC involves activated cell survival pathways, but there is a lack of the significant oncogenic drivers for targeted therapies. Thus, novel drugs and targets that can be exploited, are required. The pathways reported to be involved in hepatocarcinogenesis were retrieved from KEGG database (HCC, MAPK, calcium, p53, PI3K-Akt, Wnt, TGF-B, NAFLD and apoptosis) and a directed network with 801 node...
Molecular characterization of the effects of valdecoxib on colon cancer cell lines (ht29 & sw620) using ATR-FTIR spectroscopy İnan Genç, Aysun; Severcan, Feride; Banerjee, Sreeparna; Department of Biochemistry (2014) Colorectal cancer is the third most common malignancy and the fourth most frequent cause of cancer deaths worldwide, with 945,000 estimated new cases and 492,000 deaths per year in industrialized countries. Chronic inflammation of the bowel is associated with increased levels of pro-inflammatory cytokines and the increased signaling, which plays important roles in the development of carcinoma. During chronic inflammation COX-2 levels are dramatically increased which is the main enzyme in the arachidonic aci...
A new triazolothiadiazine derivative inhibits stemness and induces cell death in HCC by oxidative stress dependent JNK pathway activation Kahraman, Deniz Cansen; Guven, Ebru Bilget; Aytac, Peri S.; Aykut, Gamze; Tozkoparan, Birsen; Atalay, Rengul Cetin (2022-09-01) Hepatocellular carcinoma (HCC) is a highly heterogeneous cancer, and resistant to both conventional and targeted chemotherapy. Recently, nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to decrease the incidence and mortality of different types of cancers. Here, we investigated the cellular bioactivities of a series of triazolothiadiazine derivatives on HCC, which have been previously reported as potent analgesic/anti-inflammatory compounds. From the initially tested 32 triazolothiadiazine NSAI...
MECHANISMS OF SYNERGISTIC ANTITUMOR EFFECT OF NAPROXEN AND SORAFENIB IN HEPATOCELLULAR CARCINOMA Akar, Etkin; Muyan, Mesut; Kahraman, Deniz Cansen; Department of Biology (2023-1-23) Hepatocellular carcinoma (HCC) is life-threatening cancer that accounts for the second leading cause of cancer-related deaths worldwide. Due to the complexity and heterogeneity of HCC, which leads to resistance to current targeted therapies, combination therapy becomes an important strategy. Since 90% of HCC arises from chronic liver inflammation, HCC drugs combined with non-steroid anti- inflammatory drugs (NSAIDs) are considered an important strategy to increase treatment efficacy. In this study, we aimed...

Citation Formats

I. D. Sahin et al., “A small library of chalcones induce liver cancer cell death through Akt phosphorylation inhibition,” Scientific Reports, 2020, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/51439.